Mahoney granted 1,654 Bunge RSUs as director pay
Mahoney Christopher reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mahoney Christopher reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Christopher Mahoney received an equity award tied to company stock. The filing shows a grant of 1,654 shares of common stock in the form of Restricted Stock Units, which are expected to vest in full on May 20, 2027. After this award, Mahoney directly holds 8,311 shares of Bunge common stock. This appears to be a routine director compensation grant rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,654 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge common stock. RSUs are expected to vest in full on May 20, 2027.
Key Figures
Key Terms
Restricted Stock Units ("RSUs") financial
vest in full financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Bunge (BG) director Christopher Mahoney report in this Form 4?
What type of equity award did Christopher Mahoney receive from Bunge (BG)?
When do Christopher Mahoney’s Bunge (BG) RSUs from this grant vest?
Was this Bunge (BG) Form 4 an open-market stock purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.